Insider Buying: iCoreConnect Inc. (NASDAQ:ICCT) CEO Buys 236,785 Shares of Stock

iCoreConnect Inc. (NASDAQ:ICCT) CEO Robert P. Mcdermott acquired 236,785 shares of the company’s stock in a transaction on Monday, November 25th. The stock was purchased at an average cost of $0.18 per share, for a total transaction of $42,621.30. Following the completion of the transaction, the chief executive officer now owns 1,229,885 shares in the company, valued at approximately $221,379.30. The trade was a 23.84 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website.

iCoreConnect Stock Down 4.0 %

NASDAQ:ICCT traded down $0.01 during trading hours on Friday, hitting $0.17. The company’s stock had a trading volume of 732,782 shares, compared to its average volume of 1,288,592. The stock has a market capitalization of $4.06 million, a P/E ratio of -0.06 and a beta of 0.77. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of 7.93. The stock has a fifty day moving average of $0.26 and a 200-day moving average of $0.56. iCoreConnect Inc. has a 52-week low of $0.15 and a 52-week high of $3.20.

iCoreConnect Company Profile

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.